Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

350
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
350
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

996
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
996
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

495
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
495
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

404
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
404
Reaction Mechanisms03:06

Reaction Mechanisms

30.6K
Chemical reactions often occur in a stepwise fashion, involving two or more distinct reactions taking place in a sequence. A balanced equation indicates the reacting species and the product species, but it reveals no details about how the reaction occurs at the molecular level. The reaction mechanism (or reaction path) provides details regarding the precise, step-by-step process by which a reaction occurs.
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
30.6K
Mechanical Protein Functions01:58

Mechanical Protein Functions

5.5K
Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force. 
5.5K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Quality of care for migrant populations with type 2 diabetes mellitus in Italy: a retrospective analysis of data from the the Italian AMD (Associations of Medical Diabetologists) annals initiative.

Acta diabetologica·2026
Same author

Association between electronic cigarette use and prediabetes, diabetes, and insulin resistance: a systematic review and meta-analysis.

Internal and emergency medicine·2026
Same author

Causes and consequences of discontinuation of GLP1RAs or tirzepatide.

Nature reviews. Endocrinology·2026
Same author

A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.

The lancet. Diabetes & endocrinology·2026
Same author

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

Cardiovascular diabetology·2026
Same author

Environmental Pollutant-Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics.

The Canadian journal of cardiology·2026
Same journal

Navigating the Computational Landscape for Drug Repurposing.

Annual review of pharmacology and toxicology·2026
Same journal

Treating Pregnant and Lactating Women: Insights from Clinical Pharmacology.

Annual review of pharmacology and toxicology·2026
Same journal

<i>Caenorhabditis elegans</i> as a Model System for Environmental Mitotoxicants.

Annual review of pharmacology and toxicology·2025
Same journal

Introduction to the Theme "New Approaches, Technology, and Techniques That Advance Pharmacology and Toxicology".

Annual review of pharmacology and toxicology·2025
Same journal

A Mechanistic Framework for Repurposing FDA-Approved Drugs to Combat Antimicrobial Resistance: The Case of <i>Staphylococcus aureus</i>.

Annual review of pharmacology and toxicology·2025
Same journal

Early Detection of Wellness-to-Disease Transitions in the AI Era: Implications for Pharmacology and Toxicology.

Annual review of pharmacology and toxicology·2025
関連記事をすべて見る

関連する実験動画

Updated: Jan 25, 2026

Sampling and Identification of Microplastics in Groundwater
08:27

Sampling and Identification of Microplastics in Groundwater

Published on: November 7, 2025

1.1K

マイクロプラスチックとアテローム性動脈硬化症:メカニズム

Raffaele Marfella1,2, Francesco Prattichizzo3, Michelangela Barbieri1,2

  • 1Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy;

Annual review of pharmacology and toxicology
|January 23, 2026
PubMed
まとめ
この要約は機械生成です。

マイクロプラスチックおよびナノプラスチック(MNP)は、生物学的プロセスを妨害することにより、心血管系の健康に影響を与える可能性があります。MNPと心血管疾患との関連を明確にするためには、高度な検出技術を用いたさらなる研究が必要です。

キーワード:
心血管疾患炎症質量ベースのアプローチマイクロ・ナノプラスチックオミクスアプローチ酸化ストレス粒子ベース法

さらに関連する動画

Separation and Identification of Conventional Microplastics from Farmland Soils
14:10

Separation and Identification of Conventional Microplastics from Farmland Soils

Published on: March 21, 2025

3.2K
Protocol for Microplastics Sampling on the Sea Surface and Sample Analysis
10:16

Protocol for Microplastics Sampling on the Sea Surface and Sample Analysis

Published on: December 16, 2016

50.8K

関連する実験動画

Last Updated: Jan 25, 2026

Sampling and Identification of Microplastics in Groundwater
08:27

Sampling and Identification of Microplastics in Groundwater

Published on: November 7, 2025

1.1K
Separation and Identification of Conventional Microplastics from Farmland Soils
14:10

Separation and Identification of Conventional Microplastics from Farmland Soils

Published on: March 21, 2025

3.2K
Protocol for Microplastics Sampling on the Sea Surface and Sample Analysis
10:16

Protocol for Microplastics Sampling on the Sea Surface and Sample Analysis

Published on: December 16, 2016

50.8K

科学分野:

  • 環境保健
  • 毒物学
  • 心血管科学

背景:

  • マイクロプラスチックおよびナノプラスチック(MNP)は、健康への影響の可能性がある環境汚染物質です。
  • 摂取、吸入、または皮膚接触によって曝露が発生し、細胞プロセスの混乱につながる可能性があります。
  • MNPは心血管疾患の一因であると疑われていますが、直接的な関連はまだ十分に確立されていません。

研究 の 目的:

  • ヒト組織におけるMNPの検出と特性評価のための現在の技術をレビューすること。
  • MNPがヒトの健康、特に心血管系に影響を与える既知のメカニズムを要約すること。
  • MNPが心血管系の健康に及ぼす影響を理解するために、さらなる研究の必要性を強調すること。

主な方法:

  • MNPの検出と特性評価のための既存の分析技術に関する文献レビュー。
  • MNPと生物学的システムとの相互作用に関する現在の科学的理解の合成。
  • MNPが心血管系の健康に及ぼす影響を調査した研究への焦点。

主要な成果:

  • MNPは、オートファジー、炎症、酸化ストレス、免疫応答、血管機能などの主要な生物学的経路を妨害する可能性があります。
  • 組織中のMNP濃度と心血管疾患の発症との相関に関する現在のデータは一貫していません。
  • 分析技術の進歩は、将来の研究にとって不可欠です。

結論:

  • MNPは、さまざまな生物学的破壊メカニズムを通じて心血管系の健康に潜在的なリスクをもたらします。
  • MNPの存在を正確に定量化し、その用量依存的な影響を理解するためには、より堅牢な分析方法が必要です。
  • MNP曝露と心血管疾患の発症との決定的な関連を確立するためには、さらなる前向き研究が必要です。